Southwest Gas Corporation (NYSE:SWX) shares moved up 2.25% in last trading session and ended the day at $60.81. SWX Gross Margin is 75.20% and its has a return on assets of 2.70%. Southwest Gas Corporation (NYSE:SWX) quarterly performance is 10.62%.
The Board of Directors for Southwest Gas Corporation (NYSE: SWX) has declared the
Dividend of $0.405 per share which is payable on 1st December, 2015 on the record date of 16 November, 2015.
TransEnterix, Inc. (NYSEMKT:TRXC) ended the last trading day at $2.38. Company weekly volatility is calculated as 7.47% and price to cash ratio as 2.83. TransEnterix, Inc. (NYSEMKT:TRXC) showed a weekly performance of 0.85%.
On 1st October, TransEnterix, Inc. (NYSE MKT: TRXC), announced that Anthony Fernando, an executive with significant global experience, has been appointed to lead the integration of SOFAR’s robotic surgery division and named Managing Director of TransEnterix Italia. Mr. Fernando joined TransEnterix in August 2015 as Vice President International Development and was an integral part of the evaluation and structuring of the SOFAR robotics division acquisition. Mr. Fernando will report directly to TransEnterix’s CEO Todd M. Pope.
On 12 October, Yandex N.V. (NASDAQ:YNDX) shares decreased -1.46% and was closed at $12.19. YNDX EPS growth in last 5 year was 51.20%. Yandex N.V. (NASDAQ:YNDX) year to date (YTD) performance is -32.13%.
Yandex (NASDAQ:YNDX) announced it will report its financial results for the quarter ended September 30, 2015, on Tuesday, October 27, 2015. On that day, management will hold a conference call and webcast at 8:00 a.m. U.S. Eastern Time (3:00 p.m. Moscow time, 12:00 p.m. London time) to review and discuss the Company’s results for the third quarter.
Arrowhead Research Corp. (NASDAQ:ARWR) shares decreased -5.43% in last trading session and ended the day at $5.57. ARWR has a return on assets of -68.80%. Arrowhead Research Corp. (NASDAQ:ARWR) quarterly performance is -20.09%.
Arrowhead Research Corporation (NASDAQ:ARWR), announced that the company will present at the 11th Annual Meeting of the Oligonucleotide Therapeutics Society – Leiden, the Netherlands, October 11-14, 2015.
CEMEX, S.A.B. de C.V. (NYSE:CX) caters to the Industrial Goods space. It has a net profit margin of -3.10% and weekly performance is 4.90%. On the last day of trading company shares ended up at $7.71. CEMEX, S.A.B. de C.V. (NYSE:CX) distance from 50-day simple moving average (SMA50) is 0.91%.
Zacks upgraded shares of Cemex SAB de CV (NYSE:CX) from a hold rating to a buy rating in a research report report published on Wednesday, Market Beat Ratings reports. They currently have $8.75 price target on the stock.
Leave a Reply